Zacks Investment Research cut shares of Kindred Healthcare, Inc. (NYSE:KND) from a hold rating to a sell rating in a report issued on Wednesday.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Other analysts have also issued research reports about the company. UBS AG reaffirmed a neutral rating and issued a $10.50 target price (up previously from $8.00) on shares of Kindred Healthcare in a research note on Friday, May 5th. BidaskClub lowered Kindred Healthcare from a buy rating to a hold rating in a research note on Wednesday, July 12th. Mizuho reaffirmed a neutral rating and issued a $9.00 target price on shares of Kindred Healthcare in a research note on Monday, July 3rd. Royal Bank Of Canada reaffirmed a hold rating and issued a $10.00 target price on shares of Kindred Healthcare in a research note on Monday, May 15th. Finally, Deutsche Bank AG cut their target price on Kindred Healthcare from $13.00 to $10.00 and set a buy rating for the company in a research note on Monday, August 7th. Five analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of $9.94.

Shares of Kindred Healthcare (KND) opened at 7.90 on Wednesday. Kindred Healthcare has a 1-year low of $5.65 and a 1-year high of $11.90. The firm’s market capitalization is $687.45 million. The stock has a 50 day moving average of $8.75 and a 200-day moving average of $9.28.

Kindred Healthcare (NYSE:KND) last issued its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.59 billion. Kindred Healthcare had a positive return on equity of 3.49% and a negative net margin of 16.31%. Kindred Healthcare’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.38 earnings per share. On average, equities analysts expect that Kindred Healthcare will post $0.48 earnings per share for the current year.

WARNING: This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/kindred-healthcare-inc-knd-cut-to-sell-at-zacks-investment-research/1537996.html.

Hedge funds have recently added to or reduced their stakes in the stock. TFS Capital LLC bought a new stake in Kindred Healthcare during the first quarter worth $104,000. Point72 Asia Hong Kong Ltd bought a new stake in Kindred Healthcare during the first quarter worth $121,000. First Citizens Bank & Trust Co. raised its stake in Kindred Healthcare by 8.9% in the first quarter. First Citizens Bank & Trust Co. now owns 15,462 shares of the health services provider’s stock worth $129,000 after buying an additional 1,260 shares during the period. Janus Henderson Group PLC bought a new stake in Kindred Healthcare during the second quarter worth $130,000. Finally, Two Sigma Securities LLC raised its stake in Kindred Healthcare by 54.5% in the first quarter. Two Sigma Securities LLC now owns 15,632 shares of the health services provider’s stock worth $131,000 after buying an additional 5,511 shares during the period. 88.72% of the stock is owned by hedge funds and other institutional investors.

About Kindred Healthcare

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.